129 related articles for article (PubMed ID: 23035194)
1. Comparison of hybrid capture II, linear array, and a bead-based multiplex genotyping assay for detection of human papillomavirus in women with negative pap test results and atypical squamous cells of undetermined significance.
Comar M; Iannacone MR; Casalicchio G; McKay-Chopin S; Tommasino M; Gheit T
J Clin Microbiol; 2012 Dec; 50(12):4041-6. PubMed ID: 23035194
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with Amplicor HPV and Hybrid Capture 2 assays for detection of high-grade lesions of the uterine cervix.
Dufresne S; Sauthier P; Mayrand MH; Petignat P; Provencher D; Drouin P; Gauthier P; Dupuis MJ; Michon B; Ouellet S; Hadjeres R; Ferenczy A; Franco EL; Coutlée F
J Clin Microbiol; 2011 Jan; 49(1):48-53. PubMed ID: 21084508
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the GenoFlow human papillomavirus (HPV) test and the Linear Array assay for HPV screening in an Asian population.
Wong OG; Lo CK; Chow JN; Tsun OK; Szeto E; Liu SS; Ngan HY; Cheung AN
J Clin Microbiol; 2012 May; 50(5):1691-7. PubMed ID: 22337983
[TBL] [Abstract][Full Text] [Related]
4. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study.
Castle PE; Gravitt PE; Solomon D; Wheeler CM; Schiffman M
J Clin Microbiol; 2008 Jan; 46(1):109-17. PubMed ID: 17989194
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the detection of HPV-16, 18, 31, 33, and 45 by type-specific DNA- and E6/E7 mRNA-based assays of HPV DNA positive women with abnormal Pap smears.
Salimović-Bešić I; Tomić-Čiča A; Smailji A; Hukić M
J Virol Methods; 2013 Dec; 194(1-2):222-8. PubMed ID: 24036071
[TBL] [Abstract][Full Text] [Related]
6. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
7. Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay.
Schmitt M; Dondog B; Waterboer T; Pawlita M; Tommasino M; Gheit T
J Clin Microbiol; 2010 Jan; 48(1):143-9. PubMed ID: 19864475
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus detection and typing in thin prep cervical cytologic specimens comparing the Digene Hybrid Capture II Assay, the Roche Linear Array HPV Genotyping Assay, and the Kurabo GeneSquare Microarray Assay.
Ermel A; Qadadri B; Morishita A; Miyagawa I; Yamazaki G; Weaver B; Tu W; Tong Y; Randolph M; Cramer H; Brown D
J Virol Methods; 2010 Oct; 169(1):154-61. PubMed ID: 20670658
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; Guimerà N; Torne A; Ordi J
J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
[TBL] [Abstract][Full Text] [Related]
10. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
11. Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay.
Galati L; Combes JD; Le Calvez-Kelm F; McKay-Chopin S; Forey N; Ratel M; McKay J; Waterboer T; Schroeder L; Clifford G; Tommasino M; Gheit T
Microbiol Spectr; 2022 Apr; 10(2):e0148021. PubMed ID: 35225653
[TBL] [Abstract][Full Text] [Related]
12. High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Intaraphet S; Siriaunkgul S
J Med Virol; 2016 Jan; 88(1):135-43. PubMed ID: 26129775
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche Linear Array HPV genotyping assay.
Liu SS; Leung RC; Chan KK; Cheung AN; Ngan HY
J Clin Microbiol; 2010 Mar; 48(3):758-64. PubMed ID: 20042614
[TBL] [Abstract][Full Text] [Related]
14. Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with the linear array HPV genotyping PCR assay and influence of DNA extraction method on HPV detection.
Roberts CC; Swoyer R; Bryan JT; Taddeo FJ
J Clin Microbiol; 2011 May; 49(5):1899-906. PubMed ID: 21346041
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of an array-based method for human papillomavirus detection and genotyping in comparison with conventional methods used in cervical cancer screening.
García-Sierra N; Martró E; Castellà E; Llatjós M; Tarrats A; Bascuñana E; Díaz R; Carrasco M; Sirera G; Matas L; Ausina V
J Clin Microbiol; 2009 Jul; 47(7):2165-9. PubMed ID: 19439534
[TBL] [Abstract][Full Text] [Related]
16. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
[TBL] [Abstract][Full Text] [Related]
17. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction.
Riethmuller D; Gay C; Bertrand X; Bettinger D; Schaal JP; Carbillet JP; Lassabe C; Arveux P; Seilles E; Mougin C
Diagn Mol Pathol; 1999 Sep; 8(3):157-64. PubMed ID: 10565688
[TBL] [Abstract][Full Text] [Related]
18. Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology.
Castle PE; Eaton B; Reid J; Getman D; Dockter J
J Clin Microbiol; 2015 Apr; 53(4):1277-81. PubMed ID: 25653409
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a liquid bead array system for high-risk human papillomavirus detection and genotyping in comparison with Hybrid Capture II, DNA chip and sequencing methods.
Cho EJ; Do JH; Kim YS; Bae S; Ahn WS
J Med Microbiol; 2011 Feb; 60(Pt 2):162-171. PubMed ID: 20965919
[TBL] [Abstract][Full Text] [Related]
20. Comparison of analytical and clinical performances of the digene HC2 HPV DNA assay and the INNO-LiPA HPV genotyping assay for detecting high-risk HPV infection and cervical neoplasia among HIV-positive African women.
Ngou J; Gilham C; Omar T; Goumbri-Lompo O; Doutre S; Michelow P; Kelly H; Didelot MN; Chikandiwa A; Sawadogo B; Delany-Moretlwe S; Meda N; Costes V; Mayaud P; Segondy M
J Acquir Immune Defic Syndr; 2015 Feb; 68(2):162-8. PubMed ID: 25394189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
